Wolverine Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282K | Buy |
16,198
+2,770
| +21% | +$48.3K | ﹤0.01% | 849 |
|
|
2025
Q1 | $326K | Buy |
13,428
+2,852
| +27% | +$69.2K | ﹤0.01% | 843 |
|
|
2024
Q4 | $337K | Sell |
10,576
-2,622
| -20% | -$83.6K | ﹤0.01% | 1007 |
|
|
2024
Q3 | $389K | Buy |
13,198
+3,982
| +43% | +$117K | ﹤0.01% | 763 |
|
|
2024
Q2 | $354K | Sell |
9,216
-3,082
| -25% | -$118K | ﹤0.01% | 786 |
|
|
2024
Q1 | $723K | Buy |
12,298
+5,579
| +83% | +$328K | ﹤0.01% | 515 |
|
|
2023
Q4 | $402K | Sell |
6,719
-15,655
| -70% | -$937K | ﹤0.01% | 773 |
|
|
2023
Q3 | $851K | Buy |
+22,374
| New | +$851K | ﹤0.01% | 398 |
|
|
2023
Q2 | – | Sell |
-5,966
| Closed | -$394K | – | 1115 |
|
|
2023
Q1 | $394K | Buy |
+5,966
| New | +$394K | ﹤0.01% | 577 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1203 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1547 |
|
|
2021
Q4 | – | Sell |
-33,143
| Closed | -$1.13M | – | 1716 |
|
|
2021
Q3 | $1.13M | Buy |
+33,143
| New | +$1.13M | ﹤0.01% | 636 |
|